Leo International Precision Health (LIPH) is building an active healthcare platform that unites AI-driven precision health assets across biotech, medtech, healthtech and healthcare services.
Increasing quality of life of cancer patients is a critical component of comprehensive oncology care. The addition of UHO Wellness Corporation, a Taiwan-based company specializing in the development and delivery of complementary nutraceuticals and healthcare solutions for cancer patients, strategically strengthens LIPH’s portfolio.
uho wellness co.’s flagship product, MSC Complex Polysaccharide Capsules, is made from extracts of active 𝞫-glucans with a purity of ≥60% from five precious edible and medicinal fungi and utilizes a unique ‘Frozen Extraction' ultra-low temperature process to obtain natural active enzymes and glycoproteins, combined with a patented encapsulation technology for immune regulation and antioxidant effects.
uho wellness co. also operates the Phoenix Cancer Patient Program, a nutritional support scheme designed to enhance post-surgical recovery and improve quality of life for cancer patients.
Find out more about UHO Wellness Corporation: https://lnkd.in/dynN_a9e
